https://www.selleckchem.com/pr....oducts/bozitinib.htm
6% vs. 32.6% at 12 months and 34.8% vs. 36.1% at 24 months) and HbA1c (T2D subgroup; 38.3 vs. 41.6mmol/mol at 12 months and 37.0 vs. 39.6mmol/mol at 24 months) and comparable improvement in BP (hypertension subgroup) and resolution of OSA (87.5% vs. 88.2% at 24 months). In women with PCOS with morbid obesity, gastric bypass resulted in significant weight loss and metabolic outcomes similar to women without PCOS. In women with PCOS with morbid obesity, gastric bypass resulted in significant weight loss and metabolic outcomes similar to
Like
Comment
Share
